EEuropean Urology2/13/2026A0580 Preliminary results of a phase II study to evaluate the efficacy and safety of disitamab vedotin (RC48-ADC) in combination with radiotherapy for adjuvant therapy in upper tract urothelial carcinomaZ. Tao·C. J. Xu·X. K. Li·X. Guo·Q. TangRead at European UrologyTagsBladder and Urothelial Cancer TreatmentsSurgery
